Chemistry Ventures — the venture capital firm built by veterans of Bessemer Venture Partners, Index Ventures, and Andreessen Horowitz — is targeting $500 million for its second fund.

A Pedigreed Team Goes Bigger

The firm brings together some of the most recognizable names in venture capital. Its founding team's collective track record spans some of the industry's most celebrated funds, lending Chemistry Ventures immediate credibility with LPs.

Raising a $500M Fund II represents a significant step up in scale, signaling that the firm's debut fund performed well enough to attract renewed and expanded LP interest.

What It Means for the Market

The fundraise arrives amid a more selective LP environment, where capital is increasingly concentrating around managers with strong brand recognition and verifiable returns.

  • Firm: Chemistry Ventures
  • Fund: Second fund
  • Target size: $500 million
  • Founding pedigree: Bessemer, Index Ventures, a16z alumni

For a relatively young firm, closing at or near its target would mark a strong vote of confidence from institutional investors navigating a cautious deployment cycle.